- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 309/06 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 309/06
Total number of patents in this class: 288
10-year publication summary
|
23
|
17
|
16
|
17
|
16
|
11
|
15
|
11
|
18
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| JNC Corporation | 1514 |
13 |
| JNC Petrochemical Corporation | 328 |
12 |
| Bristol-myers Squibb Company | 4795 |
10 |
| Acucela Inc. | 157 |
10 |
| Syngenta Limited | 441 |
9 |
| Galderma Research & Development | 377 |
7 |
| XENIOPRO GmbH | 16 |
7 |
| Takeda Pharmaceutical Company Limited | 2710 |
6 |
| Ono Pharmaceutical Co., Ltd. | 425 |
6 |
| The Salk Institute for Biological Studies | 450 |
6 |
| Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd. | 200 |
6 |
| Daiichi Sankyo Company, Limited | 1877 |
5 |
| DIC Corporation | 3889 |
5 |
| Jiangsu Hecheng Display Technology Co., Ltd. | 187 |
5 |
| The Research Foundation for The State University of New York | 1685 |
5 |
| F. Hoffmann-La Roche AG | 7893 |
4 |
| Chisso Petrochemical Corporation | 56 |
4 |
| The University of Melbourne | 558 |
4 |
| Syngenta Crop Protection AG | 53 |
4 |
| Merck Patent GmbH | 5727 |
3 |
| Other owners | 157 |